AcelRx Pharma (ACRX) Misses Q3 EPS by 2c

November 1, 2016 4:31 PM EDT
Get Alerts ACRX Hot Sheet
Trade ACRX Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

AcelRx Pharma (NASDAQ: ACRX) reported Q3 EPS of ($0.25), $0.02 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $1.6 million versus the consensus estimate of $2.89 million.

For earnings history and earnings-related data on AcelRx Pharma (ACRX) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment